Postural and Balance Disorders in Patients with Parkinson’s Disease: A Prospective Open-Label Feasibility Study with Two Months of Action Observation Treatment

Table 3

Functional findings of 15 patients with Parkinson’s disease at baseline () and at the end of the 8-week program of action observation treatment (AOT) (). Data are presented as mean ± standard deviation (SD) and 95% confidence interval (95% CI).

Outcome measures		95% CI		95% CI	Score differences	value
BBS	42.9 ± 6.9	39.0–46.7	44.8 ± 7.0	40.9–48.7	−1.93	0.3706
ABC-16	49.8 ± 13.8	42.2–57.5	51.9 ± 13.9	44.2–59.6	−2.09	0.5201
10MWT (s)	16.1 ± 3.3	14.2–17.9	15.0 ± 3.3	13.2–16.9	1.04	0.1645
TUGo (s)	15.3 ± 4.2	12.9–17.6	14.1 ± 4.1	11.8–16.3	1.21	0.3613
UPDRS III	23 ± 13.1	15.7–30.2	22.1 ± 13.0	14.8–29.2	0.93	0.8031

95% CI: 95% confidence interval; BBS: Berg Balance Scale; ABC-16: Activities-Specific Balance Confidence Scale; 10MWT: 10-Meter Walk Test; TUG: Timed Up and Go Test; UPDRS III: Unified Parkinson’s Disease Rating Scale, part III.